使用光敏聚合物药物合物对子中子捕获疗法的药物动力学进行活性控制
Daiki Tokura1, Kakeru Konarita1, Minoru Suzuki2
1Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan.
概括
这项研究引入了一种用于中子捕获疗法 (BNCT) 的新型聚合物药物合物. 合物允许控制释放和快速清除药物,增强瘤中的治疗效果.
科学领域:
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
- 癌症治疗 癌症治疗
背景情况:
- 中子捕获疗法 (BNCT) 需要高内口度和从正常组织快速清除.
- 在BNCT中,同时实现瘤积累和药物快速清除是一个重大挑战.
研究的目的:
- 开发一种聚合物-药物联合物来积极控制血中的药物清除.
- 通过优化药物药理动力学来提高BNCT的治疗疗效.
主要方法:
- 一种生物相容的聚合物通过光性链接剂与低分子量药物结合.
- 结合物被静脉注射,其积累和释放动力学被研究在小鼠皮下瘤模型中.
- 光辐射被用来触发药物释放和从血液中清除.
主要成果:
- 聚合物-药物合物在瘤中累积,达到高瘤与正常组织度比 (∼10).
- 光照射成功地切割了链接器,从而使药物从血液中快速清除.
- 在没有光照射的瘤中维持了高度的,从而使BNCT具有强大的效果.
结论:
- 开发的聚合物-药物合物为BNCT中临时控制药物释放和清除提供了一种方法.
- 这种方法可以通过尽量减少正常组织暴露来增加对瘤的治疗辐射剂量.
- 该策略有望提高BNCT的临床疗效.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


